The 2nd International Hepatitis E Symposium will bring together leading experts in hepatitis E virus (HEV) research, presenting new data and updates on HEV, a serious though often neglected disease. Over the course of this 2-day meeting, participants will engage in presentations, panels, and discussion around the latest findings in HEV epidemiology, diagnostics, and control. This symposium aims to promote scientific collaboration around the globe and advocate for HEV prevention efforts on the public health agenda. Registration will close April 1, 2023, or when the event has reached capacity.

April 28-29, 2023 | London, United Kingdom

Planned sessions include:

• Global HEV epidemiology and disease burden
• Updates on HEV diagnostics and laboratory research
• Current HEV treatment options and clinical research
• Hecolin® and other HEV vaccines: where do we stand?
• HEV control efforts and policy
• One Health

Abstract submission is now closed

The Scientific Program Committee invites submission of original abstracts relevant to hepatitis E virus epidemiology, diagnostics, vaccines, and policy. All submitted abstracts will be considered for both oral and poster presentations, and accepted abstracts will be included in the symposium program materials.

The symposium is also pleased to offer a limited number of travel awards to support researchers from historically under-represented backgrounds and young scientists.